Therapeutic issues
The following issues should be considered:
- when to start interferon therapy?
- interferon does not reverse disability which argues for early intervention, however
- 10-20% of patients with MS have a benign course and would not benefit from interferon treatment
- perhaps early treatment should be considered in patients with a poor prognosis
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.